You just read:

Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs

News provided by

Digna Biotech

03 Feb, 2011, 10:00 GMT